United States Genitourinary Drugs Market Report 2016

Publisher Name :
Date: 12-Oct-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies sales (consumption) of Genitourinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Astellas

- Pfizer

- GlaxoSmithKline

- Eli Lilly

- Bayer AG

- Merck

- Abbott Laboratories

- Bristol-Myers Squibb

- Genentech

- Roche

- Amgen

- Botex

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Sex Hormones

- Urologicals

- Genitourinary Anti-Infectives

- Gynaecologicals

Split by applications, this report focuses on sales, market share and growth rate of Genitourinary Drugs in each application, can be divided into

- Genitourinary Cancer

- Bladder Cancer

- Cervical Cancer

- Kidney/Renal Cancer

- Ovarian Cancer

- Prostate Cancer

United States Genitourinary Drugs Market Report 2016

Table of Contents
United States Genitourinary Drugs Market Report 2016
1 Genitourinary Drugs Overview
1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
1.2.1 Sex Hormones
1.2.2 Urologicals
1.2.3 Genitourinary Anti-Infectives
1.2.4 Gynaecologicals
1.3 Application of Genitourinary Drugs
1.3.1 Genitourinary Cancer
1.3.2 Bladder Cancer
1.3.3 Cervical Cancer
1.3.4 Kidney/Renal Cancer
1.3.5 Ovarian Cancer
1.3.6 Prostate Cancer
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Genitourinary Drugs (2011-2021)
1.4.1 United States Genitourinary Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Genitourinary Drugs Revenue and Growth Rate (2011-2021)
2 United States Genitourinary Drugs Competition by Manufacturers
2.1 United States Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Genitourinary Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Genitourinary Drugs Average Price by Manufactures (2015 and 2016)
2.4 Genitourinary Drugs Market Competitive Situation and Trends
2.4.1 Genitourinary Drugs Market Concentration Rate
2.4.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Genitourinary Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Genitourinary Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Genitourinary Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Genitourinary Drugs Price by Type (2011-2016)
3.4 United States Genitourinary Drugs Sales Growth Rate by Type (2011-2016)
4 United States Genitourinary Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Genitourinary Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Genitourinary Drugs Manufacturers Profiles/Analysis
5.1 Astellas
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Genitourinary Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Pfizer
5.2.2 Genitourinary Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
5.3.2 Genitourinary Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Eli Lilly
5.4.2 Genitourinary Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Bayer AG
5.5.2 Genitourinary Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Merck
5.6.2 Genitourinary Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Abbott Laboratories
5.7.2 Genitourinary Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb
5.8.2 Genitourinary Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Genentech
5.9.2 Genitourinary Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Roche
5.10.2 Genitourinary Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Amgen
5.12 Botex
6 Genitourinary Drugs Manufacturing Cost Analysis
6.1 Genitourinary Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Genitourinary Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Genitourinary Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Genitourinary Drugs Market Forecast (2016-2021)
10.1 United States Genitourinary Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Genitourinary Drugs Sales Forecast by Type (2016-2021)
10.3 United States Genitourinary Drugs Sales Forecast by Application (2016-2021)
10.4 Genitourinary Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Type in 2015
Figure Sex Hormones Picture
Figure Urologicals Picture
Figure Genitourinary Anti-Infectives Picture
Figure Gynaecologicals Picture
Table Application of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Application in 2015
Figure Genitourinary Cancer Examples
Figure Bladder Cancer Examples
Figure Cervical Cancer Examples
Figure Kidney/Renal Cancer Examples
Figure Ovarian Cancer Examples
Figure Prostate Cancer Examples
Figure United States Genitourinary Drugs Sales and Growth Rate (2011-2021)
Figure United States Genitourinary Drugs Revenue and Growth Rate (2011-2021)
Table United States Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table United States Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 United States Genitourinary Drugs Revenue Share by Manufacturers
Table United States Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genitourinary Drugs Average Price of Key Manufacturers in 2015
Figure Genitourinary Drugs Market Share of Top 3 Manufacturers
Figure Genitourinary Drugs Market Share of Top 5 Manufacturers
Table United States Genitourinary Drugs Sales by Type (2011-2016)
Table United States Genitourinary Drugs Sales Share by Type (2011-2016)
Figure United States Genitourinary Drugs Sales Market Share by Type in 2015
Table United States Genitourinary Drugs Revenue and Market Share by Type (2011-2016)
Table United States Genitourinary Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Genitourinary Drugs by Type (2011-2016)
Table United States Genitourinary Drugs Price by Type (2011-2016)
Figure United States Genitourinary Drugs Sales Growth Rate by Type (2011-2016)
Table United States Genitourinary Drugs Sales by Application (2011-2016)
Table United States Genitourinary Drugs Sales Market Share by Application (2011-2016)
Figure United States Genitourinary Drugs Sales Market Share by Application in 2015
Table United States Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Genitourinary Drugs Sales Growth Rate by Application (2011-2016)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Genitourinary Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Genitourinary Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Genitourinary Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Genitourinary Drugs Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Genitourinary Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Genitourinary Drugs Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Genitourinary Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Genitourinary Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Genitourinary Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Genitourinary Drugs Sales Market Share (2011-2016)
Table Botex Basic Information List
Table Botex Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Botex Genitourinary Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure United States Genitourinary Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Genitourinary Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Genitourinary Drugs Production Forecast by Type (2016-2021)
Table United States Genitourinary Drugs Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Dental Bone Graft Substitutes Market Professional Survey Report 2017
    Published: 27-Apr-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Dental Bone Graft Substitutes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Geistlich - Zimmer - DePuy Synthes - Biomet - S......
  • Asia-Pacific Interferon Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Interferon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Interferon for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Hyaluronic Acid Solution Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the Asia-Pacific Hyaluronic Acid Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Hyaluronic Acid Solution for these regions, from 2012 to 2022 (forecast), including - China - Japan - Sou......
  • Asia-Pacific Gastrointestinal Surgery Tissue Adhesive Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the Asia-Pacific Gastrointestinal Surgery Tissue Adhesive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Surgery Tissue Adhesive for these regions, from 2012 to 2022 (forecast), including - Chi......
  • Asia-Pacific Citrus Bioflavonoids Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Citrus Bioflavonoids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Citrus Bioflavonoids for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Bioresorbable Implants Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the Asia-Pacific Bioresorbable Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Bioresorbable Implants for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kor......
  • Asia-Pacific Anti-Infectives Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Anti-Infectives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Infectives for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Albendazole Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the Asia-Pacific Albendazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Albendazole for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • EMEA (Europe, Middle East and Africa) Vascular Endothelial Growth Factor Inhibitor Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Vascular Endothelial Growth Factor Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Vascular Endothelial Growth Factor Inhibitor for these regions, from 2012 to 2022 (forecast) - Europe:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs